ICD-9 Code 205.32
Myeloid sarcoma, in relapse
Not Valid for Submission
205.32 is a legacy non-billable code used to specify a medical diagnosis of myeloid sarcoma, in relapse. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
ICD-9: | 205.32 |
Short Description: | Myel sarcoma in relapse |
Long Description: | Myeloid sarcoma, in relapse |
Convert 205.32 to ICD-10
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
- C92.32 - Myeloid sarcoma, in relapse
Code Classification
-
Neoplasms (140–239)
-
Malignant neoplasm of lymphatic and hematopoietic tissue (200-208)
- 205 Myeloid leukemia
-
Malignant neoplasm of lymphatic and hematopoietic tissue (200-208)
Information for Medical Professionals
ICD-9 Footnotes
General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.